Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

被引：28
|
作者：
Chalhoub, Hussein [1 ]
Tunney, Michael [2 ]
Elborn, J. Stuart [2 ]
Vergison, Anne [3 ]
Denis, Olivier [4 ]
Plesiat, Patrick [5 ]
Kahl, Barbara C. [6 ]
Van Bambeke, Francoise [1 ]
Tulkens, Paul M. [1 ]
机构：
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium
[2] Queens Univ Belfast, CF & Airways Microbiol Res Grp, Belfast, Antrim, North Ireland
[3] Hop Univ Enfants Reine Fabiola, Unite Malad Infect, Brussels, Belgium
[4] Free Univ Brussels, Hop Erasme, Lab Microbiol, B-1070 Brussels, Belgium
[5] Hop Jean Minjoz, Lab Bacteriol, F-25030 Besancon, France
[6] Univ Hosp Munster, Med Microbiol, Munster, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2015年 / 70卷 / 05期
关键词：
carbapenemases; extended-spectrum beta-lactamases; ESBLs; beta-lactamase inhibition; P; aeruginosa; IN-VITRO ACTIVITY; EXACERBATIONS;
D O I：
10.1093/jac/dku551
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1596 / 1598
页数：4
相关论文
共 50 条
  • [21] PSEUDOMONAS-AERUGINOSA FROM CYSTIC-FIBROSIS PATIENTS - SUSCEPTIBILITY TESTING OF ORAL ISOLATES
    KAUFMAN, AK
    LINDEMANN, RA
    NEWMAN, MG
    LE, TV
    JOURNAL OF DENTAL RESEARCH, 1984, 63 : 186 - 186
  • [22] Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis
    Moskowitz, SM
    Foster, JM
    Emerson, J
    Burns, JL
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) : 1915 - 1922
  • [23] Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients
    Redero, Mar
    Lopez-Causape, Carla
    Aznar, Javier
    Oliver, Antonio
    Blazquez, Jesus
    Prieto, Ana I.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (10) : 2770 - 2776
  • [24] In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Nolan, Patrick J.
    Jain, Raksha
    Cohen, Leah
    Finklea, James D.
    Smith, Tiffeny T.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (02)
  • [25] In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Christenson, JC
    Korgenski, EK
    Daly, JA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 899 - 901
  • [26] Resistance Genes and Molecular Epidemiology in Ceftazidime- Avibactam-Resistant Pseudomonas aeruginosa Isolates
    Arici, Neslihan
    Tanriverdi, Elif Seren
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2023, 12
  • [27] Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against ceftazidime-resistant pseudomonas aeruginosa clinical blood strains in Tunisia
    Ben Mansour, N.
    Sallem, N.
    Basma, M.
    CLINICA CHIMICA ACTA, 2024, 558 : 58 - 58
  • [28] Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates
    Qing, Yun
    Cao, Kai-Yuan
    Fang, Zhi-Li
    Huang, Ying-Min
    Zhang, Xue-Fei
    Tian, Guo-Bao
    Huang, Xi
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 386 - 392
  • [29] Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Vettoretti, Lucie
    Plesiat, Patrick
    Muller, Cedric
    El Garch, Farid
    Phan, Gilles
    Attree, Inna
    Ducruix, Arnaud
    Llanes, Catherine
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1987 - 1997
  • [30] Draft Genome Sequences of 63 Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Sputum
    Spilker, Theodore
    LiPuma, John J.
    GENOME ANNOUNCEMENTS, 2016, 4 (02)
12345